A
A

Amgen

交易方向

交易者脈動

技術摘要

小時

財經新聞

Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court

Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court By John Kruzel and Andrew Chung WASHINGTON, March 27 (Reuters) - The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc AMGN.O to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA SASY.PA called a "blatant attempt" to squeeze competitors out of the market.
A
R
S

REUTERS NEWS SCHEDULE AT 10 p.m. GMT /6:00 a.m. SGT

REUTERS NEWS SCHEDULE AT 10 p.m. GMT /6:00 a.m. SGT Here are the top stories and upcoming coverage plans for Reuters text service as of 10 p.m. GMT /6:00 a.m. SGT. For a full schedule of news and events, go to our editorial calendar on Reuters Connect . TOP STORIES GLOBAL ISRAEL-POLITICS-JUDICIARY/ Netanyahu sacks defence minister who opposed judicial overhaul JERUSALEM (Reuters) - Israeli Prime Minister Benjamin Netanyahu on Sunday dismissed Defence Minister Yoav Gallant a day after he broke ra
A
F
R
S
T
L

Nvidia turns to AI cloud rental to spread new technology

UPDATE 4-Nvidia turns to AI cloud rental to spread new technology Adds analyst, details of Nvidia product offerings By Stephen Nellis March 21 (Reuters) - Nvidia Corp NVDA.O Chief Executive Jensen Huang on Tuesday laid out the company's plans to make the powerful and expensive supercomputers used to develop AI technologies like ChatGPT available for rent to nearly any business.
A
A
A
G
I
M
N
A
A
S

Amgen to cut 450 jobs in second round of layoffs this year

UPDATE 2-Amgen to cut 450 jobs in second round of layoffs this year Adds background March 16 (Reuters) - Amgen Inc AMGN.O said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices and high inflation. "We made these changes to realign our expense base in the face of intensifying pressure on drug prices and high levels of inflation," a company spokeswoman said in a statement to Reute
A

Amgen to cut 450 jobs in second round of layoffs this year

UPDATE 2-Amgen to cut 450 jobs in second round of layoffs this year Adds background March 16 (Reuters) - Amgen Inc AMGN.O said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices and high inflation. "We made these changes to realign our expense base in the face of intensifying pressure on drug prices and high levels of inflation," a company spokeswoman said in a statement to Reute
A

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明